Papers
1
Total Citations
6
H-Index
1
About
Jingwei Lu is a rising innovator at the intersection of biomaterials and microfluidics, whose work is redefining high-throughput drug screening. His research centers on developing smart, heterogeneous organohydrogels that enable automated, interference-free gradient feeding of drugs directly onto cell microarrays. This breakthrough addresses a critical bottleneck in cell-based assays: the need for precise, dynamic drug gradients without the complexity of robotic systems. In his most-cited 2024 paper, Lu demonstrates a platform that seamlessly integrates material design with automated fluid control, allowing for real-time, multi-dose drug testing in tiny droplets—a feat that promises to accelerate both drug discovery and toxicology studies. While his citation count is still growing, the foundational nature of this work has already garnered attention for its potential to replace cumbersome, equipment-heavy setups with a simpler, more reliable solution. Lu’s contributions are paving the way for next-generation cell screening tools that are both high-throughput and user-friendly, marking him as a key figure to watch in the field of advanced biomedical microdevices.
Research Focus
Key Achievements
Top Papers
- 1